Sign-Up for News
    -Click Here-

 Educ Mtg 93Hx140W


  Biogen Nov2017

This is a clinical trial for Patients with Urinary Incontinence, who have Multiple Sclerosis…

Reset Font Size

If you or a loved one experience MS-related urinary incontinence (UI), or involuntary urine leakage, new options may be available.

Clinical trials help to find new treatments for a variety of conditions, such as UI due to MS, and we would like to let you know about a new trial that is now enrolling.

This trial is testing whether Dysport®, which is already approved for other conditions, can help reduce UI in people living with MS for whom oral medications have not worked well.

You or your loved one may be able to take part if you or he/she:

  • Are between 18 and 80 years of age;
  • Have MS;
  • Have UI due to MS;
  • Have not responded well to oral medications; and
  • Are routinely performing clean intermittent catheterization.

To learn more and to see if you or your loved one may be able to take part, please click here.

As you may know, MS Views and News (MSVN) recently partnered with Antidote, a digital health company, to offer a new clinical trial search tool on our website that will make learning about and connecting with MS clinical trials easier than ever. If this UI trial is not of interest to you, we encourage you to check out the search tool and learn more about other MS-related research trials in ydour area.

Antidote Logo - Close

Antidote is a digital health company that provides access to the latest clinical trials. Antidote’s match tool makes it simple for anyone to search and learn more about condition-specific clinical trials in an effort to make medical research more accessible to everyone.


MS Views and News (MSVN) does not endorse or have any control or relationship with the service being provide